Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10

Blood

Volumn 90, Issue 6, 1997, Pages 2390-2397

  Zeidler, Reinhard ^a   Eissner, Günther ^b   Meissner, Petra ^b   Uebel, Stephan ^b   Tampé, Robert ^b   Lazis, Sabine ^b   Hammerschmidt, Wolfgang ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; INTERLEUKIN 10; MESSENGER RNA; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0030881322     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.6.2390.2390_2390_2397     Document Type: Article

References (46)

1. Farrell PJ: Epstein-Barr virus immortalizing genes. Trends Microbiol 3:105, 1995
2. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967, 1992
3. Miller G, Lipman M: Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190, 1973
4. Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, DeMars R: A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348:744, 1990
5. Deverson EV, Gow IR, Coadwell WJ, Monaco JJ, Butcher GW, Howard JC: MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 348:738, 1990
6. Monaco JJ, Cho S, Attaya M: Transport protein genes in the murine MHC: Possible implications for antigen processing. Science 250:1723, 1990
7. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A: Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature 348:741, 1990
8. Androlewicz MJ, Anderson KS, Cresswell P: Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci USA 90:9130, 1993
9. Schumacher TN, De-Bruijn ML, Vernie LN, Kast WM, Melief CJ, Neefjes JJ, Ploegh HL: Peptide selection by MHC class I molecules. Nature 350:703, 1991
10. Ljunggren HG, Stam NJ, Ohlen C, Neefjes JJ, Hoglund P, Heemels MT, Bastin J, Schumacher TN, Townsend A, Karre K, Ploegh HL: Empty MHC class I molecules come out in the cold. Nature 346:476, 1990
11. Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K: Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443, 1989
12. Jackson MR, Peterson PA: Assembly and intracellular transport of MHC class I molecules. Annu Rev Cell Biol 9:207, 1993
13. Neefjes JJ, Momburg F, Hämmerling GJ: Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769, 1993
14. Schouten GJ, van der Eb AJ, Zantema A: Downregulation of MHC class I expression due to interference with p105-NFκB1 processing by Ad12E1A. EMBO J 14:1498, 1995
15. Rotem-Yehudar R, Winograd S, Sela S, Coligan J, Ehrlich R: Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic Adenovirus 12. J Exp Med 180:477, 1994
16. Pääbo S, Nilsson T, Peterson PA: Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci USA 83:9665, 1986
17. York IA, Roop C, Andrews DW, Riddell SR, Graham FL, Johnson DC: A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525, 1994
18. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG: Inhibition of antigen processing by the internal repeat of the Epstein-Barr virus nuclear antigen-1. Nature 375:685, 1995
19. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL: The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmatic reticulum to the cytosol. Cell 84:769, 1996
20. Früh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, Yang Y: A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415, 1995
21. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
22. Hunter WM, Greenwood FC: Preparation of iodine-131 labelled human growth hormone with high specific activity. Nature 194:495, 1962
23. Androlewicz MJ, Cresswell P: Human transporters asssociated with antigen processing possess a promiscuous peptide-binding site. Immunity 1:7, 1994
24. Goldblum N, Daefler S, Llana T, Ablashi D, Josephs S, Salahuddin Z: Susceptibility to HIV-1 infection of a human B-lymphoblastoid cell line, DG75, transfected with subgenomic DNA fragments of Epstein-Barr virus. Dev Biol Stand 72:309, 1990
25. Moore KW, Vieira P, Fiorentino DF, Trounesteine ML, Khan TA, Mosmann TR: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 248:1230, 1990
26. Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, deVries JE, Roncarolo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88:1172, 1991
27. Taga H, Taga K, Wang F, Chretien J, Tosato G: Human and viral interleukin-10 in acute Epstein-Barr virus-induced infectious mononucleosis. J Infect Dis 171:1374, 1995
28. Hudson GS, Bankier AT, Satchwell SC, Barrell BG: The short unique region of the B95-8 Epstein-Barr virus genome. Virology 147:81, 1985
29. Miyazaki I, Cheung RK, Dosch H-M: Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp Med 178:439, 1993
30. Stewart JP, Behm FG, Arrand JR, Rooney CM: Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines. Virology 200:724, 1994
31. de Waal-Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915, 1991
32. Porcelli S, Morita CT, Brenner MB: CD1b restricts the response of human CD4-8-T lymphocytes to a microbial antigen. Nature 360:593, 1992
33. de la Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, Salamero J, Powis SH, Donato L, Bausinger H, Laforet M, Jeras M, Spehner D, Bieber T, Falkenrodt A, Cazenave J-P, Trowsdale J, Tongio M-M: Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265:237, 1994
34. Thomssen H, Kahan M, Londei M: Differential effects of interleukin-10 on the expression of HLA class II and CD1 molecules induced by granulocyte/macrophage colony-stimulating factor/interleukin-4. Eur J Immunol 25:2465, 1995
35. Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JP-Y: Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med 181:1459, 1995
36. Kornfeld R, Kornfeld S: Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631, 1985
37. Taga K, Tosato G: IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148:1143, 1992
38. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151:1224, 1993
39. Gazzinelli RT, Oswald IP, James SL, Sher A: IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 148:1792, 1992
40. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell IV: TH2 clones secrete a factor that inhibits cytokine production by TH1 clones. J Exp Med 170:2081, 1989
41. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang Q-J, Masucci MG, Kiessling R: Interleukin 10 pretreatment protects target cells from tumor-and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180:2371, 1994
42. Lenoir GM, Vuillaume M, Bonnardel C: Burkitt's lymphoma, in Lenoir GM, O'Conor G, Olweny CLM (eds): Burkitt's Lymphoma: A Human Cancer Model. Lyon, France, IARC, 1985, p 309
43. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR, Trowsdale J, Moss DJ, Rickinson AB: Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: Coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol 25:1374, 1995
44. Miyashita EM, Yang B, Lam KMC, Crawford DH, Thorley-Lawson DA: A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593, 1995
45. Benjamin D, Park CD, Sharma V: Human B cell interleukin 10. Leuk Lymphoma 12:205, 1994
46. Wiertz EJ, Mukherjee S, Ploegh HL: Viruses use stealth technology to escape from the host immune system [In Process Citation]. Mol Med Today 3:116, 1997